Pilot Study of Tolerability and Effectivity Following Application of Two Combination Topical Acne Products Clindamycin 1% and 0.025% Tretinoin Gel (Acnatac Gel), Adapalen 0,1% and Benzoyl Peroxide 2,5% Gel (Epiduo Gel)

Trial Profile

Pilot Study of Tolerability and Effectivity Following Application of Two Combination Topical Acne Products Clindamycin 1% and 0.025% Tretinoin Gel (Acnatac Gel), Adapalen 0,1% and Benzoyl Peroxide 2,5% Gel (Epiduo Gel)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Adapalene/benzoyl peroxide (Primary) ; Clindamycin/tretinoin (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Acronyms PREFECT
  • Sponsors GWT-TUD GmbH
  • Most Recent Events

    • 18 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 11 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top